EUVIMEDEUVIMED entdecken
Crossref

Thrombomodulin and CXCL6 Altered Expression in Preeclampsia: Serum‐Placental Biomarker Correlations and Clinical Significance

Xiaobao Lai, Lihua Sheng, Zhihua Liao, Shan Wu, Mengqi Lin, Xin Zeng, Pan Huang, Weiming Yang, Juanjuan Chen iD

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Xiaobao Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang, China. Hauptthemen laut MEDLINE: Thrombomodulin, Pre-Eclampsia, Placenta, Chemokine CXCL6. Die Arbeit nennt 30 Literaturangaben. Gefördert von: the Project of Science and Technology Department of Jiangxi Province, the Science and Technology Plan of Health Commission of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to examine the expression levels of thrombomodulin (THBD) and C‐X‐C motif ligand 6 (CXCL6/GCP‐2) in the serum and placental tissues of pregnant women with preeclampsia (PE) and assess their clinical significance.

Methods

In this cross‐sectional study, a cohort comprising 96 pregnant women diagnosed with preeclampsia (PE) and 119 healthy pregnant counterparts was selected from Jiangxi Maternal and Child Health Hospital, encompassing January 2024 to December 2024. The levels of THBD and CXCL6 in serum and placental tissues were assessed. The Mann‒Whitney U test was used to compare the differences between two groups, and the Spearman test was used to evaluate the risk factors for PE via correlation analysis.

Results

Serum THBD and CXCL6 levels were significantly elevated in the PE group compared to controls ( p < 0.001), with a positive correlation between the two markers ( r = 0.41, p < 0.001). Immunohistochemical analysis demonstrated reduced THBD and CXCL6 expression in placental syncytiotrophoblasts ( p < 0.05), alongside diminished THBD immunoreactivity in vascular endothelial cells ( p < 0.05). Multivariate logistic regression identified CXCL6, uric acid (UA), and lactate dehydrogenase (LDH) as independent risk factors for PE, while albumin (Alb) emerged as a protective factor ( p < 0.05).

Conclusions

In pregnant women with PE, the serum levels of THBD and CXCL6 are increased, whereas their expression in placental tissue is decreased. CXCL6 emerges as an independent risk factor for PE, with expression patterns independent of gestational age confounding, while THBD shows PE‐specific gestational age‐related effects that provide additional insights into disease pathophysiology. These findings indicate that the inflammatory response and insufficient trophoblast invasion may play important roles in the pathogenesis of PE, providing a new theoretical basis for the early diagnosis and targeted intervention of PE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombomodulinPre-EclampsiaPlacentaChemokine CXCL6HumansFemalePregnancyAdultBiomarkersCross-Sectional StudiesClinical Relevance

Stichwörter der Autor:innen

chemokine CXCL6 (CXCL6/GCP‐2)clinical relevancepre‐eclampsia (PE)thrombomodulin (THBD)

Substanzen

ThrombomodulinBiomarkersTHBD protein, humanChemokine CXCL6CXCL6 protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
  • School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Department of Operating Room, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
  • Department of Obstetrics, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
  • Department of Pathology, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

ORCID-Profile: Juanjuan Chen

Förderung

  • the Project of Science and Technology Department of Jiangxi Province
  • the Science and Technology Plan of Health Commission of Jiangxi Province

Zitieren

APA

Lai, X., Sheng, L., Liao, Z., Wu, S., Lin, M., Zeng, X., Huang, P., Yang, W., & Chen, J. (2025). Thrombomodulin and CXCL6 Altered Expression in Preeclampsia: Serum‐Placental Biomarker Correlations and Clinical Significance. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70192

Vancouver

Lai X, Sheng L, Liao Z, Wu S, Lin M, Zeng X, et al. Thrombomodulin and CXCL6 Altered Expression in Preeclampsia: Serum‐Placental Biomarker Correlations and Clinical Significance. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70192

BibTeX
@article{Lai2025,
  author = {Lai, Xiaobao and Sheng, Lihua and Liao, Zhihua and Wu, Shan and Lin, Mengqi and Zeng, Xin and Huang, Pan and Yang, Weiming and Chen, Juanjuan},
  title = {Thrombomodulin and CXCL6 Altered Expression in Preeclampsia: Serum‐Placental Biomarker Correlations and Clinical Significance},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70192}
}
Kostenlos starten →